Please follow and like us:
Transgender women — at high risk of HIV acquisition — are a key population for HIV prevention and treatment efforts. A new study reveals that more than half of transgender living with HIV in Los Angeles were concerned that taking both antiretroviral therapy to treat HIV and feminizing hormone therapy (HT) may cause harmful drug-drug interactions. Many surveyed cited these concerns as a reason for not taking anti-HIV medications, HT, or both.
Powered by WPeMatico